Cargando…

Effect of MUC1/β-catenin interaction on the tumorigenic capacity of pancreatic CD133(+) cells

Despite the fact that the biological function of cluster of differentiation (CD)133 remains unclear, this glycoprotein is currently used in the identification and isolation of tumor-initiating cells from certain malignant tumors, including pancreatic cancer. In the present study, the involvement of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sousa, Andreia Mota, Rei, Margarida, Freitas, Rita, Ricardo, Sara, Caffrey, Thomas, David, Leonor, Almeida, Raquel, Hollingsworth, Michael Anthony, Santos-Silva, Filipe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998183/ https://www.ncbi.nlm.nih.gov/pubmed/27602113 http://dx.doi.org/10.3892/ol.2016.4888

Ejemplares similares

MUC1 regulates cyclin D1 gene expression through p120 catenin and β-catenin
por: Liu, X, et al.
Publicado: (2014)

Impact of MUC1 Mucin Downregulation in the Phenotypic Characteristics of MKN45 Gastric Carcinoma Cell Line
por: Costa, Natália R., et al.
Publicado: (2011)

GALNT6 Promotes Tumorigenicity and Metastasis of Breast Cancer Cell via β-catenin/MUC1-C Signaling Pathway
por: Mao, Yingge, et al.
Publicado: (2019)

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
por: Friel, Anne M, et al.
Publicado: (2010)

GALNT6 Promotes Tumorigenicity and Metastasis of Breast Cancer Cell via β-catenin/MUC1-C Signaling Pathway: Erratum
por: Mao, Yingge, et al.
Publicado: (2021)

Cell membrane-anchored MUC4 promotes tumorigenicity in epithelial carcinomas
por: Xia, Pengpeng, et al.
Publicado: (2016)

Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling)
por: Hanson, Ryan L., et al.
Publicado: (2016)

Human MUC4 mucin induces ultra-structural changes and tumorigenicity in pancreatic cancer cells
por: Moniaux, N, et al.
Publicado: (2007)

Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells
por: Lakshmanan, Imayavaramban, et al.
Publicado: (2015)

Significance of CD133 as a cancer stem cell markers focusing on the tumorigenicity of pancreatic cancer cell lines
por: Lee, Hyun Joo, et al.
Publicado: (2011)

SOX2 functions as a molecular rheostat to control the growth, tumorigenicity and drug responses of pancreatic ductal adenocarcinoma cells
por: Wuebben, Erin L., et al.
Publicado: (2016)

CDX-2, MUC-2 and B-catenin as intestinal markers in pure mucinous carcinoma of the breast
por: García-Labastida, Laura, et al.
Publicado: (2014)

MicroRNA-200c Modulates the Expression of MUC4 and MUC16 by Directly Targeting Their Coding Sequences in Human Pancreatic Cancer
por: Radhakrishnan, Prakash, et al.
Publicado: (2013)

Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells
por: Das, Srustidhar, et al.
Publicado: (2015)

Pro-Tumorigenic Phosphorylation of p120 Catenin in Renal and Breast Cancer
por: Kourtidis, Antonis, et al.
Publicado: (2015)

Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas
por: Yokoyama, Seiya, et al.
Publicado: (2016)

MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway
por: Zhou, Wei, et al.
Publicado: (2015)

The Tumorigenic Roles of the Cellular REDOX Regulatory Systems
por: Castaldo, Stéphanie Anaís, et al.
Publicado: (2016)

Pathobiological Implications of MUC16 Expression in Pancreatic Cancer
por: Haridas, Dhanya, et al.
Publicado: (2011)

Human osteosarcoma CD49f(−)CD133(+) cells: impaired in osteogenic fate while gain of tumorigenicity
por: Ying, Meidan, et al.
Publicado: (2012)

Tumorigenic lung tumorospheres exhibit stem-like features with significantly increased expression of CD133 and ABCG2
por: Zhao, Wensi, et al.
Publicado: (2016)

No major tumorigenic role for β-catenin in serrated as opposed to conventional colorectal adenomas
por: Yamamoto, T, et al.
Publicado: (2003)

β-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells
por: Xu, Jinhua, et al.
Publicado: (2015)

Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity
por: Koch, Claudia, et al.
Publicado: (2020)

Anti-Cadherin-17 Antibody Modulates Beta-Catenin Signaling and Tumorigenicity of Hepatocellular Carcinoma
por: Wang, Yonggang, et al.
Publicado: (2013)

Molecular Interactions between MUC1 Epithelial Mucin, β-Catenin, and CagA Proteins
por: Guang, Wei, et al.
Publicado: (2012)

Integrin α1 promotes tumorigenicity and progressive capacity of colorectal cancer
por: Li, Hai, et al.
Publicado: (2020)

MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance
por: Betge, Johannes, et al.
Publicado: (2016)

The Cytoplasmic Domain of MUC1 Induces Hyperplasia in the Mammary Gland and Correlates with Nuclear Accumulation of β-Catenin
por: Li, Yuan, et al.
Publicado: (2011)

Tumor Suppressive Role of MUC6 in Wilms Tumor via Autophagy-Dependent β-Catenin Degradation
por: Liu, Bai-Hui, et al.
Publicado: (2022)

Side population rather than CD133(+ )cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells
por: Zhou, Jianjun, et al.
Publicado: (2011)

Juglone and KPT6566 Suppress the Tumorigenic Potential of CD44(+)CD133(+) Tumor-Initiating Caco-2 Cells In Vitro and In Vivo
por: Kim, Junghoon, et al.
Publicado: (2022)

The Interaction between DNMT1 and High‐Mannose CD133 Maintains the Slow‐Cycling State and Tumorigenic Potential of Glioma Stem Cell
por: Wei, Yuanyan, et al.
Publicado: (2022)

Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells
por: López-Valero, Israel, et al.
Publicado: (2020)

Expression of MUC1 and MUC4 in Gallbladder Adenocarcinoma
por: Kim, Su-Mi, et al.
Publicado: (2012)

miR-4721, Induced by EBV-miR-BART22, Targets GSK3β to Enhance the Tumorigenic Capacity of NPC through the WNT/β-catenin Pathway
por: Tang, ZiBo, et al.
Publicado: (2020)

Role of MUC4-NIDO domain in the MUC4-mediated metastasis of pancreatic cancer cells
por: Senapati, Shantibhusan, et al.
Publicado: (2011)

Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2015)

β-Catenin Does Not Confer Tumorigenicity When Introduced into Partially Transformed Human Mesenchymal Stem Cells
por: Piperdi, Sajida, et al.
Publicado: (2012)

Galectin-3 augments tumor initiating property and tumorigenicity of lung cancer through interaction with β-catenin
por: Chung, Ling-Yen, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_el0ahmgo505gd7a5aig8cbitaf